Peer-influenced content. Sources you trust. No registration required. This is HCN.

Oncology News Central (ONC)Hijacked Cancer Trial Raises Widespread Oncology Concerns

ONC

A ransomware attack hijacked an active cancer clinical trial at the University of Hawai’i, forcing administrators to pay the ransom while the fate of stolen patient and study data remains unknown. Cancer centers nationwide face escalating cybertheft targeting the dense clinical and personal data that make oncology institutions uniquely lucrative targets.


⚖️ PROFESSIONAL IMPACT

  • A compromised trial site cannot continue enrollment or participate in other studies until systems are fully restored and verified
  • Stolen trial data is likely unusable even if recovered, unless source fidelity to the original can be independently reverified
  • Community oncology sites face equal breach risk as academic centers; underinvestment in cyber infrastructure is the primary vulnerability regardless of institution size
  • Phishing remains the primary attack vector, exploiting staff as the weakest entry point into clinical and research systems

🎯 ACTION ITEMS

  • Audit current backup infrastructure for enterprise-grade redundancy capable of sustaining trial continuity during an attack
  • Train all staff to identify phishing attempts across email, text, and phone channels
  • Establish a ransomware response protocol specific to active clinical trial data before an incident occurs
  • Evaluate migration of hosted systems to cloud-based infrastructure as a foundational security step

More in Cybersecurity

The Healthcare Communications Network is owned and operated by IQVIA Inc.

Click below to leave this site and continue to IQVIA’s Privacy Choices form